Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. | Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | ||
Founding Date | Founding Date 1999 | Founding Date 2009 | Founding Date 2013 | Founding Date 2018 |
Type | Type Public | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Needham, US HQ | Locations Vancouver, CA HQ Houston, US South San Francisco, US | Locations Los Angeles, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 50 | Employees 50 | Employees 6 | Employees 35917% increase |
Valuation ($) | Valuation ($) 222.3 m | Valuation ($) 257.8 m | Valuation ($) N/A | Valuation ($) 558.3 m |
Financial | ||||
Net income | Net income ($37.9m) (FY, 2023) | Net income ($26.6m) (FY, 2023) | Net income N/A | Net income ($332.6m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised $ 64.6m | Total funding raised $ 74.1m | Total funding raised $ 7.4m | Total funding raised $ 532m |